Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -13.14 % |
3 Month Return | + 53.23 % |
1 Year Return | + 98.33 % |
Market Stats | |
Previous Close | ₹862.55 |
Open | ₹851.35 |
Volume | 50.85K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹1,916.01Cr |
P/E Ratio | 38.22 |
PEG Ratio | 9.93 |
Market Cap | ₹1,916.01 Cr |
P/B Ratio | 3.12 |
EPS | 18.5 |
Dividend Yield | 0.45 |
Sector | Healthcare |
ROE | 13 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹1,916.01 Cr | 155.67% | 0.55 | ₹41 Cr | ₹318 Cr | |
NA | ₹1,708.94 Cr | 416.66% | 0.50 | ₹32 Cr | ₹74 Cr | |
NA | ₹110.07 Cr | 4.65% | 0.50 | ₹45 Cr | ₹59 Cr | |
NA | ₹306.98 Cr | 0.74% | 0.50 | NA | NA | |
HOLD | ₹9,717.98 Cr | 3.07% | 0.58 | ₹128 Cr | ₹1,207 Cr |
Organisation | Vimta Labs |
Headquarters | |
Industry | Healthcare |
E-voting on shares | Click here to vote |
Key events for Vimta Labs Ltd
Vimta Labs Shares Surge on Strong Earnings - 18 Dec, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, 12.28 Cr → 15.25 Cr (in ₹), with an average increase of 19.5% per quarter
Best in 1 Year
In the last 1 year, VIMTALABS has outperformed top 5 stocks with highest market-cap in Biotechnology & Medical Research
Revenue Rich
Revenue is up for the last 2 quarters, 75.57 Cr → 85.43 Cr (in ₹), with an average increase of 11.5% per quarter
Price Rise
In the last 3 months, VIMTALABS stock has moved up by 66.3%
FII Holding Up
Foreign Institutions have increased holdings from 3.31% to 3.81% in Dec 2024 quarter
MF Holding Up
Mutual Funds have increased holdings from 0.00% to 0.13% in Dec 2024 quarter
Against Peers
In the last 3 years, Shree Ganesh Remedies Ltd has given 129.0% return, outperforming this stock by 10.8%
Promoter Holding Down
Promoters have decreased holdings from 36.89% to 36.76% in Dec 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 59.80% to 58.27% in Dec 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 36.76% | ||
Foreign Institutions | 3.81% | 15.28 | |
Mutual Funds | 0.13% | 13050.00 | |
Retail Investors | 58.27% | ||
Others | 1.03% | 0.00 |
Vimta Labs in the last 5 years
Lowest (13.76x)
March 20, 2023
Today (38.22x)
January 20, 2025
Industry (97.14x)
January 20, 2025
Highest (45.24x)
January 7, 2025
Vimta Labs Ltd’s net profit jumped 140.92% since last year same period to ₹15.25Cr in the Q2 2024-2025. On a quarterly growth basis, Vimta Labs Ltd has generated 24.19% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Vimta Labs Ltd has declared dividend of ₹2 - translating a dividend yield of 0.23%.
Read More about DividendsBearish
Neutral
Bullish
Vimta Labs Ltd is currently in a Bearish trading position according to technical analysis indicators.
Vimta Labs Ltd share price today stands at ₹851.35, Open. ₹851.35 ; Previous Close. ₹862.55 ; High. ₹885 ; Low. ₹846 ; 52 Week High. ₹1069.95 ; 52 Week Low: ₹414.25.
Vimta Labs Ltd is listed on NSE
Vimta Labs Ltd is listed on BSE
PE Ratio of Vimta Labs Ltd is 38.22
PE ratio = Vimta Labs Ltd Market price per share / Vimta Labs Ltd Earnings per share
Today’s traded volume of Vimta Labs Ltd(VIMTALABS) is 50.85K.
Today’s market capitalisation of Vimta Labs Ltd(VIMTALABS) is ₹1916.01Cr.
Vimta Labs Ltd(VIMTALABS | Price |
---|---|
52 Week High | ₹1069.95 |
52 Week Low | ₹414.25 |
Vimta Labs Ltd(VIMTALABS) share price is ₹851.35. It is down -20.43% from its 52 Week High price of ₹1069.95
Vimta Labs Ltd(VIMTALABS) share price is ₹851.35. It is up 105.52% from its 52 Week Low price of ₹414.25
Vimta Labs Ltd(VIMTALABS | Returns |
---|---|
1 Day Returns | -11.2% |
1 Month Returns | -13.14% |
3 Month Returns | 53.23% |
1 Year Returns | 98.33% |